Citations

Mayo Clinic

Showing 10 of 108602 citations.

Telepsychiatry in Integrated Care Settings
Adaji, Akuh, Fortney, John, Fortney, John C.

Focus | July 18, 2017 | Volume: 15 | Issue: 3 | Pages: 257-263

10.1176/appi.focus.20170007 | PMID 31975855 Get It

Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation
Ilyas, Muneeb , Hoss, Elika, DiCaudo, David J. , Khamash, Hasan , Pittelkow, Mark R. , Sharma, Amit

Case Reports in Transplantation | July 18, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-3

10.1155/2017/4823870 | PMID 28804667 Get It

Introduction. The phenomenon of graft-versus-host disease, a solid organ transplant recipient, is a rare development with a very poor prognosis. Case Presentation. A 40-year-old woman with type 1 diabetes developed cutaneous graft-versus-host disease following second pancreas transplantation. Conclusion. The development of a nonspecific rash in the early posttransplant period following a pancreas transplant warrants suspicion for graft-versus-host disease.
Bronchoscopic Management of Airway Compression due to Fibrosing Mediastinitis
Kern, Ryan , Peikert, Tobias, Edell, Eric S. , Mullon, John J., Midthun, David E. , Utz, James P., Maldonado, Fabien , Edell, Eric, Mullon, John, Midthun, David, Utz, James, Kern, R

Annals of the American Thoracic Society | July 18, 2017 | Volume: 14 | Issue: 8 | Pages: 1353-1355

10.1513/annalsats.201610-782rl | PMID 28719233 Get It

Quantitative Assessment of Classic Anteroinferior Bony Bankart Lesions by Radiography and Computed Tomography
Lee, Seok-Beom, Amrami, Kimberly K. , Wenger, Doris E. , An, Kai‐Nan , Itoi, Eiji

The American Journal of Sports Medicine | July 18, 2017 | Volume: 31 | Issue: 1 | Pages: 112-118

10.1177/03635465030310010301 | PMID 12531767 Get It

Background An anteroinferior osseous defect of the glenoid rim is sometimes encountered in patients with recurrent anterior dislocations of the shoulder. A defect of more than 21% of the glenoid length is reported to cause instability after Bankart repair. Hypothesis We can estimate the critical size of glenoid defects by using radiography or computed tomography. Study Design A controlled laboratory study. Methods Osseous defects of 0%, 9%, 21%, 34%, and 46% of the glenoid length were created stepwise in 12 cadaveric scapulae, and plain radiographs simulating the axillary and West Point views and computed tomographic images were obtained. The maximum width of the remnant glenoid was measured under each condition and expressed as a percentage of the width of the intact glenoid. Results A 21% defect appeared to be 18.6% of the intact glenoid on the West Point view. With computed tomography, a 21% defect resulted in loss of 50% of the width on a single slice across the lower one-fourth of the glenoid. Conclusions We can estimate the size of a glenoid defect by using the West Point radiographic view or computed tomogram. Clinical Relevance These images gave decisive information as to whether an osseous glenoid defect required bone grafting to achieve stability after Bankart repair.
Caring for Patients With Chronic Physical and Mental Health Conditions: Lessons From TEAMcare and COMPASS
Niazi, Shehzad K. , Chauhan, Mohit

Focus | July 18, 2017 | Volume: 15 | Issue: 3 | Pages: 279-283

10.1176/appi.focus.20170008 | PMID 31975858 Get It

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
Guo, Yong , Krecke, Karl N. , Parisi, Joseph E. , Lucchinetti, Claudia F. , Pittock, Sean J. , Mandrekar, Jay , Dubey, Divyanshu , Debruyne, Jan, Pittock, S J , Tobin, W. Oliver , Keegan, B. Mark , Dubey, Divyanshu , Guo, Yong

Brain | July 18, 2017 | Volume: 140 | Issue: 9 | Pages: 2415-2425

10.1093/brain/awx200 | PMID 29050399 Get It

Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length
Ammann, Eric M. , Wright, Kara, Link, Brian K. , Shanafelt, Tait D. , McDowell, Bradley D. , Chrischilles, Elizabeth A. , Link, Brian K

Leukemia & Lymphoma | July 18, 2017 | Volume: 59 | Issue: 3 | Pages: 643-649

10.1080/10428194.2017.1349905 | PMID 28718694 Get It

Identification of Bodies by Unique Serial Numbers on Implanted Medical Devices
Blessing, Melissa M. , Lin, Peter T.

Journal of Forensic Sciences | July 18, 2017 | Volume: 63 | Issue: 3 | Pages: 740-744

10.1111/1556-4029.13598 | PMID 28718881 Get It

AbstractVisual identification is the most common identification method used by medical examiners but is not always possible. Alternative methods include X‐ray, fingerprint, or DNA comparison, but these methods require additional resources. Comparison of serial numbers on implanted medical devices is a rapid and definitive method of identification. To assess the practicality of using this method, we reviewed 608 consecutive forensic autopsies performed at a regional medical examiner office. Of these, 56 cases required an alternative method of identification due to decomposition (n = 35), gunshot wound (n = 9), blunt trauma (n = 6), or charring (n = 6). Of these 56 cases, eight (14.3%) were known to have an implanted medical device. Of these eight cases, five (63%) could be positively identified by comparing serial numbers. If an implanted medical device is known to be present, and medical records are available, identification by medical device serial number should be a first‐line method.
Delayed Patch-Test Reading After 5 Days: An Update From the Mayo Clinic Contact Dermatitis Group
Chaudhry, Hafsa, Drage, Lisa A., Hall, Matthew R., Killian, Jill M. , Prakash, Amy V., Yiannias, James A. , Davis, Mark D.P. , Cantwell, Hafsa M. , Chaudhry, Hafsa M, el‐Azhary, Rokea A.

Dermatitis® | July 18, 2017 | Volume: 28 | Issue: 4 | Pages: 253-260

10.1097/der.0000000000000297 | PMID 28719473 Get It

Background Patch-test readings after day 5 have previously been used to identify delayed reactions to metals and topical antibiotics. Objective The aims of this study were to identify allergens for which late readings (beyond day 5) would be most valuable and to compare our results with our previous study on delayed patch-test readings. Methods This was a retrospective study of 298 patients who underwent metal and corticosteroid series patch testing from January 1, 2007, through December 31, 2013. Patch-test readings were conducted on days 3 and 5 and at least once sometime between days 7 and 14. All reactions were examined at each reading. Conclusions These results were concordant with our previous findings that additional readings after day 7 are particularly useful for identifying reactions to metals (gold, cobalt, beryllium, palladium), specific preservatives (dodecyl gallate, propolis), and the topical antibiotic neomycin. New delayed reactions to bacitracin, p -phenylenediamine, and topical corticosteroids were not seen in this cohort.
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
Malecek, Mary‐Kate , Petrich, Adam M., Rozell, Shaina, Chu, Benjamin A., Trifilio, Steven , Galanina, Natalie , Maurer, Matthew J. , Farooq, Umar , Link, Brian K. , Nowakowski, Grzegorz S. , Nabhan, Chadi , Ayed, Ayed O. , Maurer, Matthew , Farooq, Umar , Ayed, Ayed , Link, Brian K

American Journal of Hematology | July 18, 2017 | Volume: 92 | Issue: 11 | Pages: 1156-1162

10.1002/ajh.24864 | PMID 28719025 Get It

AbstractBackgroundCentral nervous system (CNS) relapse in non‐Hodgkin lymphoma (NHL) is a rare but serious complication that carries a poor prognosis. The use of infusional etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (EPOCH‐R) for frontline treatment of diffuse large B cell lymphoma (DLBCL) is increasing, though little is known about incidence of and risk factors for CNS relapse with this regimenPatients and methodsWe completed a chart review of patients with NHL who received EPOCH‐R as front line therapy. Data obtained included baseline and treatment characteristics including if patients received CNS directed therapy. We measured overall survival (OS), progression free survival (PFS), and progression to CNS involvement.ResultsWe identified 223 patients who met the inclusion criteria, 72% had DLBCL. Of all the patients, 5.8% experienced CNS relapse, and 38.6% were treated with CNS prophylaxis. There was no difference in rate of CNS relapse, OS, or PFS between patients who had and had not received CNS prophylaxis. Patients whose serum lactate dehydrogenase was greater than twice the upper limit of normal at diagnosis and those with extranodal disease were significantly more likely to have CNS relapse (P = .0247 and 0.022, respectively) than their counterparts.ConclusionsThe rate of CNS relapse in this patient population approaches 6%, not significantly different from reports on those receiving R‐CHOP. The results of this study suggest that CNS prophylaxis might be more selectively used among patients treated with EPOCH‐R with certain high‐risk features.